Evidence map›Paper›PMID 38136703›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Antibiotic Resistance and Therapy for

Stella I Smith, Yoshio Yamaoka

Abstract readEditorial
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Helicobacter pylori eradication in the face of escalating anti-microbial resistance: Geographic heterogeneity and emerging treatment strategies.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Review
  2. Article
  3. 1,3,6-Trigalloylglucose: A Novel Potent Anti-Molecules (Basel, Switzerland) · 2024
    Article
  4. Microorganisms · 2024
    Review
  5. Chebulinic acid isolated from aqueous extracts ofFrontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stella I SmithDepartment of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Yaba, Lagos 100001, Nigeria.ORCID 0000-0003-2163-1189
Yoshio YamaokaDepartment of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Idaigaoka, Hasama-machi, Yufu 879-5593, Japan.ORCID 0000-0002-1222-5819

Funding

part by grants from Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan 18KK0266, 19H03473, 21H00346 and 22H02871
6 · The paper itself

Abstract

Approximately half of the world's population is estimated to be infected with

Identifiers

PMID38136703
PMCPMC10740761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.